Eurazeo

Here we go! 🙌 This afternoon, 17 companies from our Elevate and Capital portfolios are gathering at Google Paris for the launch of Eurazeo's first cross-portfolio AI hackathon. ➡️ Google will be home for the next 24 hours, with one goal: every team leaves with a working AI prototype, a clear path to scale, and a network of peers across the Eurazeo portfolio. Each team is tackling a real business problem it's already trying to solve, supported by Google Cloud engineers and AI experts, from SymphonyAI and Pyl.Tech, on the floor for architecture review, code guidance and real-time troubleshooting.   This AI hackathon reflects what Eurazeo wants to be for its companies: not just a provider of capital, but a partner that supports their growth and transformation. This is the kind of access that comes with being part of the Eurazeo portfolio.   The program has been in the works for weeks and will continue into the autumn to support the move to production, so the momentum built this week keeps moving forward.   More to come in the next few hours. Stay tuned! Pierre Meignen Antonin de Margerie Guillaume de Montchalin Florent Mélis Lucas Oppenheim

A little over a year ago, we laid the first foundations of an ambitious project: bringing together under one roof more than 450 employees for our Eurazeo seminar. ✨ A project that carried a real challenge as Eurazeo has grown spectacularly over the years with expanded teams and business lines and several office openings across the globe. That growth raised an important question: how do we turn One Eurazeo into more than just a communication slogan? How do we turn it into something 450 people can genuinely experience? We created all the conditions for people who might never have crossed paths to truly meet and for something lasting to emerge from those encounters. We organized meetings with exceptional guests: Philippe POTTIER, Director of the École de guerre, the sailor Samantha Davies, Yves Bonnefont and Claudia Zeisberger, Professor at INSEAD. The seminar was also an opportunity to work collectively on the challenges ahead of us in the coming months and years. ➡️ Our aim was to build a common spirit: house of champions. Because while our mission is to build European champions with global ambitions, we too aspire to rank among the finest asset managers in the world. This moment also marked the culmination of six months of work for our New Gen Lab, an internal think tank made up of more than 27 young talents from across the Group. Launched earlier this year, it came into its own during this seminar, through a series of forward-looking sessions. A heartfelt thank you to everyone who contributed to making this seminar a reality. 🤝 Christophe BAVIERE William Kadouch-Chassaing Sophie Flak Coralie France-Savin Isabelle Mathieu Laurence Branthomme Nicolas Canet Anouk Champigny Xiaolu CHEN Antoine Crouillère Zaynab El hajjami Hala Fadel Margaux Girard Adin Huseljic Elvina K. Eliott Kratiroff Adrian Kreiser Matthieu Michot Heejeong Mun Alba Nadal Violaine Namy Sharon Ouzen Teresa Rebuelta Merino Mathilde Rigalleau Pauline Rolland Jack Sasson Anjini Sharma-Saul Eric Sondag Elise Stern Mathieu Teisseire Rodolphe Triniac Victoire Vanheuverswyn Camille Wu

We’re proud to announce the final closing of Eurazeo Secondary Fund V, our fifth-generation private equity secondaries program at €2.3 billion, exceeding the initial target of €2 billion.   This closing represents a significant increase compared with Eurazeo’s previous secondaries programme, which closed at €1 billion in 2021, reflecting growing investor demand for its disciplined strategy and differentiated market positioning.   ➡️ The secondary market remains deep and highly dynamic, with attractive opportunities continuing to emerge across Europe. Our disciplined focus on European buyout assets allows us to access resilient, high-quality transactions in a segment where we have long-standing expertise. Our diversified global investor base, which includes sovereign wealth funds, pension funds, financial institutions, family offices and private wealth clients, is a testimony to our disciplined strategy and differentiated market positioning.   Huge congratulations to the team! 👏 Christophe BAVIERE Christophe Simon Amine Rais, CFA Sophie Bardsley Mahdi BENERRADI, CFA Théo Charpentier Annette Fainbloom Côme de Saint Chamas Adrienne Larson Paul Voutsinos-Svilarich Grégoire Guillaume Pauline Rolland Thanina Belgrine Hugo Faure Jules Mouradian

We’re proud to announce the sale of our stake in FST Hotels, a Spanish hotel portfolio comprising three hotels in Madrid and Barcelona, to EXTENDAM, a leading European hospitality-focused private equity firm.   This transaction marks the successful completion of the investment cycle launched in 2022, when Eurazeo and a leading institutional investor acquired FST Hotels through a joint venture.   ➡️ Over the past four years, the joint venture delivered an ambitious transformation programme, combining active portfolio management, a significant refurbishment and rebranding of the Madrid and Barcelona hotels, and the disposal of non-core regional assets. These initiatives enhanced the portfolio’s positioning and generated strong value for all stakeholders.   Through this transaction, Eurazeo reaffirms its ambition to support leading European companies at the key stages of their growth, while demonstrating the quality of its assets and its expertise in operational and real estate value creation.   Kudos to our Real Estate team: Pierre Lariviere, Riccardo Abello Thierry de Montesquiou-Fezensac, Margaux Monpert, Frederic Maman

Nous sommes ravis d’annoncer qu’EasyVista, leader européen des solutions IT, vient d’annoncer l’acquisition de la plateforme française d’agents IA Konverso. Cette opération permet à EasyVista de renforcer sa plateforme intégrée qui couvre l’ensemble de cycle de vie IT.   ➡️ Ce rapprochement intervient alors que l'IT entre dans une nouvelle ère portée par l’adoption rapide de l’IA par les organisations. Le déploiement des agents IA impose aux directions informatiques de repenser en profondeur la gestion de leurs infrastructures et de la donnée et l'automatisation des processus métiers.   L’équipe Elevate d’Eurazeo est entrée au capital d'EasyVista en septembre 2020. Au cours des 4 dernières années, EasyVista a multiplié par 3 son revenu récurrent annuel (ARR) à la faveur à fois d'une croissance organique à deux chiffres et d'acquisitions ciblées en France, aux Etats-Unis et en Allemagne. Cette nouvelle acquisition est la suite logique et la meilleure illustration de ce qui guide notre approche : construire des champions européens à l’ambition mondiale.   Nous sommes très heureux de les soutenir dans cette nouvelle phase de leur croissance.   Patrice Barbedette Bertrand LAFFORGUE Guillaume de Montchalin Clément Morin Lucas Thibault Jeanne Llorca

Big news ! Poppins, entreprise que nous accompagnons depuis 2021 à travers Kurma Partners et depuis 2023 via nos équipes Venture, vient d'obtenir le feu vert pour une prise en charge par l'Assurance Maladie. Poppins est un dispositif médical numérique thérapeutique destiné aux enfants dyslexiques de 7 à 11 ans, qui emprunte les codes du jeu vidéo pour faciliter une utilisation régulière.    ➡️ Investisseurs historiques de Poppins, nous sommes ravis de cette décision qui rend accessible à davantage de familles un dispositif médical numérique évalué scientifiquement et elle ouvre la voie à une meilleure organisation du parcours de soin.   La prise en charge sera effective dès la publication de l'arrêté au Journal officiel, attendue à l'automne 2026. François Vonthron Louis Bô 

Thrilled to announce that Kurma Partners, part of Eurazeo group, and Memo Therapeutics AG, a Kurma portfolio company, has entered into an agreement to be acquired by Ipsen for a total potential consideration exceeding €700 million.   ➡️ Kurma co-led the extension of Memo Therapeutics' Series C financing in 2024, supporting the company as it advanced its innovative antibody platform and lead clinical program.   Memo's lead candidate, Potravitug, is a first-in-class neutralizing antibody targeting BK polyomavirus (BKV) infection in kidney transplant recipients, a serious complication for which there is currently no approved treatment.   Congratulations to Kurma’s team, Hadrien Bouchez, Rémi Droller, Florence de Coorebyter and Memo Therapeutics team: Erik van den Berg, Christoph Esslinger, Juergen Beck, Frits van Alphen, Lars Spenger. 👏   Ysios Capital (Thomas Harth), Pureos Bioventures (Veronica Gambillara Fonck), Swisscanto (Ellen Rietmann Ahl), Vesalius Biocapital III (Christian Schneider), Adjuvant Capital (Philippe Dro), Fresenius Medical Care (Andreas Wüpper)

For the second consecutive year, we are proud to see our Eurazeo Sustainable Maritime Infrastructure (ESMI) fund recognised as Environmental Fund of the Year at the Sustainable Investment Awards. A meaningful recognition, coming just a few months after announcing the first closing of ESMI II.   ➡️ ESMI is Eurazeo's first Article 9 fund (SFDR), aiming to generate financial returns while actively contributing to the decarbonization of the maritime sector.   The fund supports European small and mid-sized shipowners and maritime stakeholders in financing next-generation maritime vessels, port infrastructure, and offshore renewable energy assets. In doing so, it enables the deployment of cutting-edge technologies and designs that drive CO2e emissions reduction and avoidance.   🚢 The numbers speak for themselves: the maritime sector accounts for 90% of global trade. It therefore plays a critical role in achieving Europe’s climate neutrality by 2050 and we are proud to support its transition through ESMI. Eric Gallerne, François Lacoste, Guillaume BRANCO, Romain Uhl, Joyce Dumazert, Valentin VIOLLEAU Sophie Flak, Renaud THIARD, Leslie Auriol

Last week, Paris was hosting the 2026 #OPSWF Mid-Term Meetings and last Thursday we had the pleasure of welcoming the network for a working lunch. Hard not to notice the timing: brainstorming the future of long-term, sustainable investment while Paris is in the middle of a heatwave.   Adrien Pinelli and Sophie Flak opened the brainstorming session with four questions to get the room thinking: about what it means to invest for future generations, which sustainability megatrends will reshape long-term opportunities, where sovereign and long-term investors can create value together and what the OPSWF Network should look like by 2035.   With more than 50 members and nearly $48 trillion in assets, these are powerful questions with influencial members who can transform the answers into actionnable measures.   Finally, we warmly thank Lawrence Yanovitch, Jonas Jølle, Georgios K. Barzoukas and Sikama Makany for organizing this event and Othmane Khales for coordinating Eurazeo's involvement in this network. One Planet Sovereign Wealth Funds

Thrilled to announce our investment in TargED Biopharmaceuticals, through Kurma Partners, part of Eurazeo, and through our FCPI (French innovation investment fund). This investment was made alongside BGV (BioGeneration Ventures) and the European Innovation Council Fund, as part of TargED's Series A2 round totaling €40.4 million, bringing the company's total funding to €80 million. ➡️ TargED Biopharmaceuticals, a clinical-stage biotechnology company, is developing TGD001, a first-in-class targeted thrombolytic designed to treat thrombotic diseases by degrading both von Willebrand factor and fibrin. The Phase 1 data, presented at ASH 2025 and ESOC 2026, demonstrated a favorable safety profile and potent thrombolytic activity: a compelling clinical readout in a field that has seen remarkably little therapeutic innovation in decades. This investment reflects the depth of Eurazeo's healthcare expertise and our long-term commitment to supporting scientific innovation across Europe. William Kadouch-Chassaing Rémi Droller Ania Tchorzewska Damien Fietta Alexis M. Andera Partners, Curie Capital, FIRST fund, Hadean Ventures, INKEF Capital, Sunstone Life Science Ventures Utrecht, Heart of Health Seed Fund.